Budesonide combined with UDCA to improve liver histology in primary biliary cirrhosis: a three-year randomized trial (Q45309693)

12 December 2017

Budesonide combined with UDCA to improve liver histology in primary biliary cirrhosis: a three-year randomized trial (English)

1 reference

primary biliary cholangitis

12 December 2017

0 references

0 references

author

Martti Färkkilä

7

1 reference

12 December 2017

Henna Rautiainen

1

1 reference

12 December 2017

Päivi Kärkkäinen

2

1 reference

12 December 2017

A-L Karvonen

3

1 reference

12 December 2017

Heimo Nurmi

4

1 reference

12 December 2017

Pekka Pikkarainen

5

1 reference

12 December 2017

Hannu Nuutinen

6

1 reference

12 December 2017

language of work or name

English

0 references

publication date

1 April 2005

1 reference

12 December 2017

1 reference

12 December 2017

41

1 reference

12 December 2017

4

1 reference

12 December 2017

747-752

1 reference

Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group.

12 December 2017

1 reference

Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis

21 January 2018

1 reference

Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis

21 January 2018

1 reference

Ursodeoxycholic acid for primary biliary cirrhosis: final results of a 12-year, prospective, randomized, controlled trial

21 January 2018

1 reference

Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group

21 January 2018

1 reference

Pharmacokinetics and pharmacodynamic action of budesonide in early- and late-stage primary biliary cirrhosis

21 January 2018

1 reference

The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis

21 January 2018

1 reference

Characterisation of patients with primary biliary cirrhosis responding to long term ursodeoxycholic acid treatment

21 January 2018

1 reference

Primary biliary cirrhosis

21 January 2018

1 reference

7 January 2021

Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis

1 reference

7 January 2021

Ursodeoxycholic acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosis

1 reference

7 January 2021

Oral budesonide and ursodeoxycholic acid for treatment of primary biliary cirrhosis: results of a prospective double-blind trial

1 reference

7 January 2021

Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid

1 reference

7 January 2021

Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)

1 reference

7 January 2021

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

1 reference

7 January 2021

Time course of histological progression in primary biliary cirrhosis

1 reference

7 January 2021

Primary biliary cirrhosis: incidence and predictive factors of cirrhosis development in ursodiol-treated patients

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.20646

1 reference

12 December 2017

1 reference